Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-63.84%
0%
-63.84%
1 Year
-74.26%
0%
-74.26%
2 Years
-77.36%
0%
-77.36%
3 Years
-83.7%
0%
-83.7%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Evoq Remedies for the last several years.
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
-18.30%
EBIT Growth (5y)
-189.79%
EBIT to Interest (avg)
-0.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0
Tax Ratio
29.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
25.57%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
33
Price to Book Value
0.28
EV to EBIT
-6.73
EV to EBITDA
-6.78
EV to Capital Employed
0.38
EV to Sales
2.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.62%
ROE (Latest)
1.78%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Patel Payal Bhumishth (6.02%)
Highest Public shareholder
Dhruv Ganji (11.35%)
Individual Investors Holdings
85.75%
Half Yearly Results Snapshot (Standalone) - Mar'25
Mar'25
Sep'24
Change(%)
Net Sales
11.76
0.00
Operating Profit (PBDIT) excl Other Income
-0.61
-1.64
62.80%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.71
-1.62
205.56%
Operating Profit Margin (Excl OI)
-5.19%
0.00%
-5.19%
Values in Rs Cr.
Net Sales
Growth in half year ended Mar 2025 is 0.00% vs -100.00% in Sep 2024
Standalone Net Profit
Growth in half year ended Mar 2025 is 205.56% vs -515.38% in Sep 2024
Annual Results Snapshot (Standalone) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
11.76
4.05
190.37%
Operating Profit (PBDIT) excl Other Income
-2.23
-1.64
-35.98%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.09
0.45
-80.00%
Operating Profit Margin (Excl OI)
-18.96%
-40.49%
21.53%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2025 is 190.37% vs -80.14% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is -80.00% vs -72.22% in Mar 2024
About Evoq Remedies Ltd 
Evoq Remedies Ltd
Micro Cap
Pharmaceuticals & Drugs
Evoq Remedies Limited was originally incorporated as "Salus Life Science and Research Private Limited" at Ahmedabad, Gujarat on February 24th, 2010 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, name of the Company was changed to "Evoq Remedies Private Limited" on July 15th, 2019 with Certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad.
Company Coordinates 
No Company Details Available